Marinomed Biotech AG

Marinomed Biotech AG, also known as Marinomed Biotech, is a biotechnology company. Its headquarters is situated in Austria. The firm operates within the biotech sector, though specific product lines are not detailed in the available sources. The organization is recognized by its Austrian base and the aliases under which it conducts business.

On 1 April 2025, Marinomed Biotech AG disclosed that it fell victim to a cybercrime incident involving an unauthorized transfer of approximately 677,000 euros to parties outside the European Economic Area. On 1 November 2025, the company announced a similar cybercrime event resulting in an unauthorized transfer of about EUR 677,000 to external parties. In both cases, the transferred funds were directed to recipients located outside the European Economic Area. The company characterized each incident as a victim of cybercrime. The disclosed amounts were identical, indicating a repeated financial impact of roughly six hundred seventy‑seven thousand euros.

Following each incident, Marinomed Biotech AG filed criminal charges with the relevant authorities. The company engaged external advisors to conduct investigations into the breaches. It is currently assessing whether its existing insurance policies will cover the financial losses incurred. Attempts to reverse the unauthorized transactions or to block the funds at the recipient banks have so far been unsuccessful. Management has stated that, despite the incidents, the company's liquidity remains secure or unaffected. Information about these events is sourced from a Kurier article and an official Marinomed news release.